65,437 trials
Male Infertility · Unexplained Infertility · Abortion, Habitual
Primary: Pregnancy — 67; 80 participants
Open-Angle Glaucoma · Ocular Hypertension
Primary: Mean Diurnal IOP Change From Baseline at Month 3 — -7.9; -6.5; -6.4 millimeters of mercury (mmHg)
Ascites · Cirrhosis
Primary: Time to Recurrence of Ascites. — 10; 8 days — p=<0.05
Fecal Incontinence
Primary: Mean Fecal Incontinence and Constipation Assessment (FICA) Score — 8.1; 9.1; 6.5; 7.6 units on a scale
Coronary Artery Disease
Primary: Delivery Success — 10617 stents
Advanced Melanoma
Primary: Maximum Observed Serum Concentration (Cmax) of Ipilimumab Manufactured by Process C Relative to the Cmax of Ipilimumab Manufactured by Process B - Evaluable…
Myopia
Primary: Subjective Responses for Comfort Rated on a 0-100 Visual Scale. — 86; 87; 89; 91 units on a scale
Open-angle Glaucoma
Primary: Month 12 Intraocular Pressure ≤ 18 mmHg Without Topical Hypotensive Medications — 18; 4 participants
Mucositis · Head and Neck Cancer
Primary: Number of Participants With Adverse Events (AEs) — 2; 3; 0; 2 participants
Retraction of Colostomy
Primary: Total Opioid Burden — 67.7; 38.41 mg morphine equivalent
Presbyopia
Primary: Objective Vision Assessments: High Contrast Distance Visual Acuity — -0.09; -0.05 logMAR units
Obesity
Primary: Change in Insulin Resistance After 12 Weeks of Vitamin D3 Supplementation — 0.01; -0.27 HOMA score — p=0.95
Perennial Allergic Rhinitis · Seasonal Allergic Rhinitis
Primary: Percentage of Participants Advised to Start AIT Who Elected Subcutaneous Immunotherapy (SCIT) Shots or Sublingual Immunotherapy (SLIT) Drops — 28.2; 8.0 percentage of…
Dysphagia · Non-Small Cell Lung Cancer · Lung Cancer
Primary: Number of Participants With Grade 2 or Higher Dysphagia — 32; 30; 13; 18 participants — p=0.3550
Schizophrenia
Primary: Change From Baseline in Symptom Checklist 90-R (SCL90-R) at Week 24 — 99.84; 73.03; 67.66; 13.09 Units on a scale